Four Plasma Glucose and Insulin Responses to a 75 g OGTT in Healthy Young Japanese Women. 2018

Kei Takahashi, and Hidetaka Nakamura, and Hiroshi Sato, and Hideto Matsuda, and Kazuo Takada, and Tomiko Tsuji
Department of Health and Nutrition, Faculty of Health and Human Life, Nagoya Bunri University, 365, Maeda, Inazawa-Cho, Inazawa City, Aichi, Japan.

The incidence of diabetes has been gradually increasing, not only in middle-aged individuals but also in young individuals. However, insulin and glucose patterns have not been investigated in apparently healthy young individuals, as they are typically grouped as controls. In this study, we investigated and classified glucose and insulin patterns in healthy young women. Sixty-two nonobese women without metabolic disease were recruited. The subjects underwent a 75 g oral glucose tolerance test (OGTT), physical measurements, and a biochemical examination. Two subjects displayed impaired glucose tolerance. The 62 subjects were categorized into four patterns by plasma glucose and insulin peak time during OGTT: normal type (n = 39), insulin-late type (n = 11), insulin- and glucose-late type (n = 7), and insulin-very late type (n = 5). OGTT glucose and insulin levels at all time points, insulinogenic index, HOMA-IR, and glucose area under the curve (AUC) significantly differed among the four groups. However, insulin AUC did not significantly differ. We did not detect significant differences in body condition or biochemical measurements. Our study demonstrated that some healthy young individuals might have delayed insulin secretion by OGTT. Early detection of altered glucose metabolism might be helpful to improve lifestyle choices and prevent progression to diabetes.

UI MeSH Term Description Entries
D007328 Insulin A 51-amino acid pancreatic hormone that plays a major role in the regulation of glucose metabolism, directly by suppressing endogenous glucose production (GLYCOGENOLYSIS; GLUCONEOGENESIS) and indirectly by suppressing GLUCAGON secretion and LIPOLYSIS. Native insulin is a globular protein comprised of a zinc-coordinated hexamer. Each insulin monomer containing two chains, A (21 residues) and B (30 residues), linked by two disulfide bonds. Insulin is used as a drug to control insulin-dependent diabetes mellitus (DIABETES MELLITUS, TYPE 1). Iletin,Insulin A Chain,Insulin B Chain,Insulin, Regular,Novolin,Sodium Insulin,Soluble Insulin,Chain, Insulin B,Insulin, Sodium,Insulin, Soluble,Regular Insulin
D007333 Insulin Resistance Diminished effectiveness of INSULIN in lowering blood sugar levels: requiring the use of 200 units or more of insulin per day to prevent HYPERGLYCEMIA or KETOSIS. Insulin Sensitivity,Resistance, Insulin,Sensitivity, Insulin
D007564 Japan A country in eastern Asia, island chain between the North Pacific Ocean and the Sea of Japan, east of the Korean Peninsula. The capital is Tokyo. Bonin Islands
D001786 Blood Glucose Glucose in blood. Blood Sugar,Glucose, Blood,Sugar, Blood
D005260 Female Females
D005951 Glucose Tolerance Test A test to determine the ability of an individual to maintain HOMEOSTASIS of BLOOD GLUCOSE. It includes measuring blood glucose levels in a fasting state, and at prescribed intervals before and after oral glucose intake (75 or 100 g) or intravenous infusion (0.5 g/kg). Intravenous Glucose Tolerance,Intravenous Glucose Tolerance Test,OGTT,Oral Glucose Tolerance,Oral Glucose Tolerance Test,Glucose Tolerance Tests,Glucose Tolerance, Oral
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D055815 Young Adult A person between 19 and 24 years of age. Adult, Young,Adults, Young,Young Adults
D018149 Glucose Intolerance A pathological state in which BLOOD GLUCOSE level is less than approximately 140 mg/100 ml of PLASMA at fasting, and above approximately 200 mg/100 ml plasma at 30-, 60-, or 90-minute during a GLUCOSE TOLERANCE TEST. This condition is seen frequently in DIABETES MELLITUS, but also occurs with other diseases and MALNUTRITION. Impaired Glucose Tolerance,Glucose Intolerances,Glucose Tolerance, Impaired,Glucose Tolerances, Impaired,Impaired Glucose Tolerances,Intolerance, Glucose,Intolerances, Glucose,Tolerance, Impaired Glucose,Tolerances, Impaired Glucose

Related Publications

Kei Takahashi, and Hidetaka Nakamura, and Hiroshi Sato, and Hideto Matsuda, and Kazuo Takada, and Tomiko Tsuji
June 1986, Diabete & metabolisme,
Kei Takahashi, and Hidetaka Nakamura, and Hiroshi Sato, and Hideto Matsuda, and Kazuo Takada, and Tomiko Tsuji
January 1985, The Kurume medical journal,
Kei Takahashi, and Hidetaka Nakamura, and Hiroshi Sato, and Hideto Matsuda, and Kazuo Takada, and Tomiko Tsuji
September 1989, Diabetes research (Edinburgh, Scotland),
Kei Takahashi, and Hidetaka Nakamura, and Hiroshi Sato, and Hideto Matsuda, and Kazuo Takada, and Tomiko Tsuji
November 2018, Journal of diabetes investigation,
Kei Takahashi, and Hidetaka Nakamura, and Hiroshi Sato, and Hideto Matsuda, and Kazuo Takada, and Tomiko Tsuji
November 1988, Annals of clinical biochemistry,
Kei Takahashi, and Hidetaka Nakamura, and Hiroshi Sato, and Hideto Matsuda, and Kazuo Takada, and Tomiko Tsuji
March 2008, Journal of the Medical Association of Thailand = Chotmaihet thangphaet,
Kei Takahashi, and Hidetaka Nakamura, and Hiroshi Sato, and Hideto Matsuda, and Kazuo Takada, and Tomiko Tsuji
May 2020, Irish journal of medical science,
Kei Takahashi, and Hidetaka Nakamura, and Hiroshi Sato, and Hideto Matsuda, and Kazuo Takada, and Tomiko Tsuji
January 2012, Endocrine journal,
Kei Takahashi, and Hidetaka Nakamura, and Hiroshi Sato, and Hideto Matsuda, and Kazuo Takada, and Tomiko Tsuji
August 1991, IEEE transactions on bio-medical engineering,
Kei Takahashi, and Hidetaka Nakamura, and Hiroshi Sato, and Hideto Matsuda, and Kazuo Takada, and Tomiko Tsuji
April 2009, The British journal of nutrition,
Copied contents to your clipboard!